AzTrials
AzTrials

Patients Undergoing Gastrointestinal EndoscopyNCT07903545

Recovery Time With the Application of ALDRETE Score in Patients Undergoing Gastrointestinal Endoscopy

A study testing The post-anesthesia recovery or Aldrete score has been commonly used to clinically assess the physical status of patients recovering from the anesthetic experience and to follow their awakening proces in people with Patients Undergoing Gastrointestinal Endoscopy, run by Konstantopoulio-Patission General Hospital of Nea Ionia at 1 site in Greece.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Over the past decades, the volume and complexity of gastrointestinal endoscopy (GI) interventions have increased due to the progress in diagnostic and therapeutic procedures along worldwide implementation of colorectal cancer screening and surveillance programs. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
The post-anesthesia recovery or Aldrete score has been commonly used to clinically assess the physical status of patients recovering from the anesthetic experience and to follow their awakening proces
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,300 participants
Where
1 siteGreece
Study dates
18 Aug 2026to 18 Aug 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients undergoing gastroscopy and/or colonoscopy
  • Age ≥ 18 years
  • Ability to understand instructions in Greek language
  • Ability to provide written informed consent

Who cannot join

  • Patients scheduled to undergo sigmoidoscopy
  • Unable to provide informed consent were excluded

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Georgios Tziatzios, Phd contact

00306942259009

g_tziatzios@yahoo.gr

Greece1 site, 1 recruiting
  • Konstantopoulio - Patision" General Hospital, Athens, Greece

    Athens, 151 27

    Georgios Tziatzios, phd, 00306942259009, g_tziatzios@yahoo.gr

    Recruiting

Other trials in Greece

About this study

Official title: Recovery Time With the Application of ALDRETE Score in Patients Undergoing Gastrointestinal Endoscopy: a Randomized Controlled Trial

Over the past decades, the volume and complexity of gastrointestinal endoscopy (GI) interventions have increased due to the progress in diagnostic and therapeutic procedures along worldwide implementation of colorectal cancer screening and surveillance programs. Nowadays, the first line for procedural sedation is either propofol or midazolam, in combination with opiates when analgesia is required, depending on the country's human resources, service framework, and legislation. Provision of sedation has been shown to decrease patient's anxiety, discomfort and pain improving at the same time procedure efficiency. However, administration of sedative and/or analgesic medications is not risk-free, as a variety of serious adverse effects i.e. respiratory depression, arrhythmia or hypotension may occur. In this regard, optimal discharge management after a procedure with sedation/analgesia, until the patient returns to a fully conscious, clinically stable, and ideally cognitively functional state can be challenging for both endoscopists and nursing personnel[6]. In an effort to address this, international endoscopy societies suggest the use of standardized discharge criteria and scoring systems such as the Post Anesthesia Recovery (PAR), or Aldrete, score, Aldrete scoring system and the modified post-anesthesia discharge scoring system (mPADSS), combined with clinical assessment to ensure patient safe discharge and readiness for discharge. Still, data supporting the use of Aldrete score derive mainly from studies evaluating patients discharge post-surgery, while evidence for model use in the setting of GI endoscopic procedures remain scant[8,9]. In this context, the investigators conducted a randomized controlled trial (RCT) aiming to explore the impact of Aldrete scoring system on safe discharge of participants who have undergone GI procedures under analgesia/sedation.

Being tested
The post-anesthesia recovery or Aldrete score has been commonly used to clinically assess the physical status of patients recovering from the anesthetic experience and to follow their awakening proces
Keywords
sedation, aldrete score, recovery

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The post-anesthesia recovery or Aldrete score has been commonly used to clinically assess the physical status of patients recovering from the anesthetic experience and to follow their awakening procesProcedure or surgery

    Patients randomized to the intervention arm upon arrival in the recovery area were assessed by endoscopy nurses experienced in Aldrete score implementation when discharging patients. The Aldrete score was calculated every 10 minutes using a structured questionnaire (Supplementary File B) and after a minimum of 10 minutes, patients could be discharged from the recovery area if their Aldrete score was ≥9, with their accompanying person. Patients assigned to the standard of care Group (SOC) were assessed in the recovery area by other endoscopy nurses in a subjective empirical manner. After a minimum of 10 minutes first, patients' vital signs and consciousness were assessed and if deemed within normal range the patient could be discharged also accompanied by the responsible person. In case the endoscopy nurse considered those requirements inadequate the patient remained in the recovery area and was re-evaluated 5 min later again assessing the same parameters. This process with 5 min interv

Study groups in NCT07903545
Study groupRoleWhat they receive
ComparatorNo interventionPatients assigned to the standard of care Group (SOC) were assessed in the recovery area by other endoscopy nurses in a subjective empirical manner. After a minimum of 10 minutes first, patients' vital signs and consciousness were assessed and if deemed within normal range the patient could be discharged also accompanied by the responsible person
Patients assessment of patients in resuscitation room using the modified ALDRETE score and exit whenActive comparatorPatients randomized to the intervention arm upon arrival in the recovery area were assessed by endoscopy nurses experienced in Aldrete score implementation when discharging patients. The Aldrete score was calculated every 10 minutes using a structured questionnaire (Supplementary File B) and after a minimum of 10 minutes, patients could be discharged from the recovery area if their Aldrete score was ≥9, with their accompanying person.
Receives: Procedure: The post-anesthesia recovery or Aldrete score has been commonly used to clinically assess the physical status of patients recovering from the anesthetic experience and to follow their awakening proces

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Recovery time

    Patients randomized to the intervention arm upon arrival in the recovery were assessed by endoscopy nurses experienced in Aldrete score implementation when discharging patients. The Aldrete score was calculated every 10 minutes using a structured questionnaire and after a minimum of 10 minutes, patients could be discharged from the recovery area if their Aldrete score was ≥9, with their accompanying person. Patients assigned to the standard of care Group (SOC) were assessed in the recovery area by other endoscopy nurses in a subjective empirical manner. After a minimum of 10 minutes first, patients' vital signs and consciousness were assessed and if deemed within normal range the patient could be discharged also accompanied by the responsible person. In case the endoscopy nurse considered those requirements inadequate the patient remained in the recovery area and was re-evaluated 5 min later again assessing the same parameters.

    Measured: From enrollment through study completion, an average of 1 year

Secondary outcomes (1)
  1. Adverse events rate

    Measured: Until the end of the study

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Oct 2026
  2. Study start18 Aug 2026
  3. Primary completion18 Apr 2027 (estimated)
  4. Study completion18 Aug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
1,300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07903545
Sponsor's protocol ID
EBΔ 9864/4-4-22
Status last verified
Oct 2026
First submitted
18 Aug 2026
Last updated
29 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing The post-anesthesia recovery or Aldrete score has been commonly used to clinically assess the physical status of patients recovering from the anesthetic experience and to follow their awakening proces in people with Patients Undergoing Gastrointestinal Endoscopy, run by Konstantopoulio-Patission General Hospital of Nea Ionia at 1 site in Greece.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 29 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Georgios Tziatzios, Phd (00306942259009, g_tziatzios@yahoo.gr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Recovery time (time frame: From enrollment through study completion, an average of 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in